We could not find any results for:
Make sure your spelling is correct or try broadening your search.
SAN FRANCISCO, CA -- (Marketwired) -- 09/04/13 -- Orgenesis, Inc. (OTCBB: ORGS), a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver...
TEL AVIV, Israel and WHITE PLAINS, N.Y., July 18, 2013 (GLOBE NEWSWIRE) -- Orgenesis Inc. (OTCBB:ORGS) ("Orgenesis" or the "Company"), a development-stage company with a novel therapeutic...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.3 | 30 | 1 | 1.42 | 0.87 | 12875 | 1.13503522 | CS |
4 | 0.15 | 13.0434782609 | 1.15 | 1.48 | 0.87 | 9006 | 1.1273304 | CS |
12 | -0.72 | -35.6435643564 | 2.02 | 2.09 | 0.87 | 24213 | 1.28539695 | CS |
26 | -7.96 | -85.9611231102 | 9.26 | 9.26 | 0.87 | 23137 | 1.28539695 | CS |
52 | -7.96 | -85.9611231102 | 9.26 | 9.26 | 0.87 | 21691 | 1.28539695 | CS |
156 | -7.96 | -85.9611231102 | 9.26 | 9.26 | 0.87 | 19645 | 1.28539695 | CS |
260 | -7.95 | -85.9459459459 | 9.25 | 9.26 | 0.87 | 17647 | 1.28539695 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions